≡
🔎︎
🔎︎
Roundtables
Podcasts
Viewpoints
Conferences
HEALTHCARE HEADLINES
FDA & Regulations
Policy & Legislation
Healthcare Systems & Business
Digital Health & AI
Workforce & Practice
Clinical Trial Updates
ONCOLOGY CARE
GU Cancers
Hematologic Malignancies
Breast Cancer
Lung & Thoracic
GI Cancers
Dermatologic Cancer
Supportive & Survivorship Care
PRECISION MEDICINE
Biomarker & Genomic Testing
Transplant Diagnostics
Liquid Biopsy & MRD
Companion Diagnostics
Cell & Gene Therapy
SPECIALTY MEDICINE
Cardiology
Dermatology & Allergy
Endocrinology & Metabolic
Pulmonology
GI & Hepatology
ID & Vaccines
NEUROLOGY & MENTAL HEALTH
Alzheimer's & Dementia
Multiple Sclerosis
Migraine & Headache
Psychiatry & Behavioral Health
Movement Disorders
Rare Neurological Diseases
ACCESS & AFFORDABILITY
Prior Authorization
Patient Assistance & Hubs
Biosimilars & Generics
Drug Pricing & Out-of-Pocket
Coverage & Appeals
MANAGED CARE
Formulary & Coverage
Value Based Care
Pharmacy Benefit Trends
Population Health Management
Payer Policy & Regulation
Financial Assistance Programs
Telehealth Adoption by Mental Health Specialists Has Not Closed the Rural Access Gap
Sonia Reyes
Medicare/Medicaid Updates
,
Financial Assistance Programs
,
Healthcare Headlines
,
Telehealth & Virtual Care
,
Care Coordination
| Mar 20, 2026
A Medicare cohort study finds telemedicine uptake barely improved mental health access in rural or shortage areas, pointing to the need for targeted policy reform.
CMS Implements Risk-Based Gene Therapy Contracting Model for State Medicaid Programs
George Padron
Medicare/Medicaid Updates
,
Financial Assistance Programs
,
Biomarker & Genomic Testing
,
Specialty Medicine
,
Policy & Legislation
,
Reimbursement Changes
| Jan 29, 2026
The federal risk-based payment model for $2.2-3.1M sickle cell gene therapies establishes a precedent as 33 states adopt a performance accountability framework.
GLP-1 Pricing Competition Intensifies as Cash-Pay Market Reshapes Obesity Treatment Access
George Padron
Financial Assistance Programs
,
Healthcare Headlines
,
Diabetes & Metabolic Diseases
| Jan 12, 2026
Novo Nordisk and Eli Lilly reduced GLP-1 obesity drug prices after compounded alternatives demonstrated superior grasp of consumer price sensitivity at JPM 2026.
House Approves ACA Subsidy Extension as Marketplace Faces Enrollment and Revenue Disruption
Sonia Reyes
Medicare/Medicaid Updates
,
Financial Assistance Programs
,
Healthcare Headlines
,
Policy & Legislation
,
Reimbursement Changes
| Jan 10, 2026
House approves ACA subsidy extension 230-196 affecting 22 million enrollees; Senate develops compromise with HSAs, income caps as premiums rise 114% on average.
Supervised Exercise Programs Mitigate Bone Loss in the Medicare Population
George Padron
Prior Authorization & Appeals
,
Real World Evidence
,
Financial Assistance Programs
| Oct 8, 2025
Structured diet and exercise intervention safely achieved weight loss without compromising bone strength in older adults, supporting Medicare behavioral programs.
Women's Health Initiative at 30: Three Decades of Evidence Reshape Postmenopausal Care
George Padron
Oncology Care
,
Financial Assistance Programs
| Jul 12, 2025
A May 2024 review by NIH researchers marks the 30-year milestone of the Women's Health Initiative (WHI).
Load More
Latest News
Dr. Eleonora Teplinsky on ASCO 2026 GLP-1 and Breast Cancer Prevention Data
Jul 20, 2026
Study Finds Parkinson's Genetic Yield Varies from 0.4% to 10.7% Based on Ancestry
Jul 18, 2026
Merck's Oral PCSK9 Inhibitor Approval Undercuts Injectables
Jul 17, 2026
Air Quality Alerts Blanket the Northeast as Canadian Smoke Pushes the AQI Into the Unhealthy Band
Jul 16, 2026
Care Partners Often Overlooked Patient Portal Users
Jul 16, 2026
Only Healthcare Today
Covering Clinical Healthcare, Access and Cost
1 Hewitt Square, Suite 139
East Northport, NY 11731
Who We Are
About Us
Editorial Policy
Contributors & Partners
Connect
Contact Us
Work With Us
Advertising
Terms of Use
Privacy Policy
x
Search
🔎︎
